Dogwood Therapeutics Inc (DWTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,525 | 14,848 | 3,317 | 7,031 | 14,008 |
| TOTAL | $8,431 | $16,545 | $4,165 | $8,370 | $15,777 |
| Non-Current Assets | |||||
| PPE Net | 13 | 17 | N/A | N/A | N/A |
| Intangibles | 81,386 | 77,523 | 0 | 0 | 0 |
| Other Non-Current Assets | 341 | 224 | 0 | 0 | 0 |
| TOTAL | $81,740 | $77,764 | $N/A | $N/A | $N/A |
| Total Assets | $90,171 | $94,308 | $4,165 | $8,370 | $15,777 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 761 | 1,232 | 112 | 573 | 354 |
| Accrued Expenses | 2,241 | 1,895 | 247 | 470 | 922 |
| TOTAL | $3,059 | $3,176 | $359 | $1,043 | $1,276 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 15,381 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 106 | 155 | 0 | 0 | 0 |
| TOTAL | $12,215 | $26,851 | $N/A | $N/A | $N/A |
| Total Liabilities | $15,274 | $30,027 | $359 | $1,043 | $1,276 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 33,402 | 1,911 | 770 | 733 | 333 |
| Common Shares | 3 | 0 | 0 | 2 | 1 |
| Retained earnings | -108,076 | -73,819 | -61,469 | -56,173 | -43,925 |
| Other shareholders' equity | -886 | 70,243 | -299 | 0 | 0 |
| TOTAL | $74,897 | $64,281 | $3,807 | $7,327 | $14,501 |
| Total Liabilities And Equity | $90,171 | $94,308 | $4,165 | $8,370 | $15,777 |